Lasting Neurological Effects of Perinatal Opioids
Lasting Neurological Effects of Perinatal Opioids
批准号:
10462821
负责人:
Seth Abrams Ament
金额:
$73.32万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-07-31
关键词:
AdolescenceAdolescentAdultAffectAgeAnimalsAnxietyBehaviorBehavioralBrainCandidate Disease GeneCell NucleusCellsChildhoodClustered Regularly Interspaced Short Palindromic RepeatsCognitiveDataDependenceDiagnosisDopamine ReceptorElectrophysiology (science)EmotionalEnrollmentEpidemicExposure toFemale AdolescentsFentanylFunctional disorderGene ExpressionGenesGoalsHealthHumanImmunohistochemistryImpairmentIncidenceInfantLeadLifeMale AdolescentsMedialMediatingMedicaidMental disordersMessenger RNAMolecularMolecular AbnormalityMothersMotivationMusNeurobiologyNeurodevelopmental ProblemNeurologic EffectNeuronsNewborn InfantNucleus AccumbensOpioidOutcomePatient Self-ReportPerinatalPerinatal ExposurePhysiologicalPopulationPrefrontal CortexPregnancyPregnant WomenPrevalencePreventionProcessPropertyRegulationRiskRoleSensorySmall Nuclear RNASynapsesTestingTimeUterusVertebral columnWeaningWomanaddictionanxiety-like behaviorbehavioral outcomecell typechild bearingdensityemotional behaviorepigenome editingmouse modelnano-stringnervous system disorderneural circuitneurobiological mechanismoffspringopioid abuseopioid exposureopioid misuseopioid useprescription opioidreward circuitrysextooltranscriptometranscriptome sequencingvirtual
中文摘要
项目摘要
近年来,阿片类药物的使用、依赖和成瘾已增加到流行病的程度,
沉重的财政和社会健康负担。超过20%参加医疗补助的孕妇是
处方阿片类药物;近年来,孕妇自我治疗的比例增加了14倍,
报告阿片类药物滥用因此,使用阿片类药物的母亲所生婴儿的发病率增加了>400%
在2000年到2012年之间。这些新生儿经常接受阿片类药物治疗,进一步增加了他们对阿片类药物的接触。
这些物质。宫内暴露于阿片类药物的婴儿神经发育风险增加
问题或不良的感觉,认知,心理和行为结果,持续的负面结果,
整个童年,甚至一生。目前,几乎没有关于神经回路的信息
适应发生在生命早期的阿片类药物暴露。
我们开发了一种小鼠模型,其中动物在对应于以下时间段内用芬太尼治疗:
人类妊娠这些老鼠表现出持久的情感行为变化,这是特定的性别。
暴露于围产期芬太尼的青少年男性表现出增强的焦虑样行为,而青少年
女性的积极性降低。我们的研究将探讨内侧前额叶皮层(mPFC)的变化
以及已知参与这些情绪行为的神经核(NAc)回路。我们将调查
围产期芬太尼暴露者mPFC和NAc细胞亚型的细胞、可塑性和分子适应
小鼠在断奶后早期直至青春期。我们将针对不同细胞中已识别的分子适应性,
亚型,以确定其在围产期芬太尼发生的回路和情绪行为中断中的作用
exposure.我们的研究将首次揭示细胞,电路和分子适应后发生的变化。
围产期暴露于芬太尼,并确定介导长期神经生物学异常的回路
这是由于围产期阿片类药物暴露引起的。
英文摘要
Project Summary
Opioid use, dependence, and addiction have increased to epidemic proportions in recent years, leading to
substantial financial and societal health burdens. More than 20% of pregnant women enrolled in Medicaid are
prescribed opioids; In recent years there was a 14-fold increase in the proportion of pregnant women self-
reporting opioid abuse. As a result, the incidence of infants born to opioid-using mothers has increased >400%
between 2000 and 2012. These newborns are often treated with opioids, further increasing their exposure to
these substances. Infants with intrauterine exposure to opioids have an increased risk for neurodevelopmental
problems or adverse sensory, cognitive, psychomotor, and behavioral outcomes, negative outcomes that last
through childhood, and likely throughout life. Currently, there is virtually no information regarding neural-circuit
adaptations occurring in with opioid exposure during early life.
We developed a mouse model in which animals are treated with fentanyl during a period corresponding to
human gestation. These mice display lasting alterations in emotional behaviors that are specific to sex.
Adolescent males exposed to perinatal fentanyl show enhanced anxiety-like behavior, while adolescent
females show reduced motivation. Our studies will investigate alterations in medial prefrontal cortex (mPFC)
and nucleus accumbens (NAc) circuitry known to be involved in these emotional behaviors. We will investigate
cellular, plasticity, and molecular adaptations in mPFC and NAc cell subtypes in perinatal fentanyl exposed
mice at early post weaning until adolescence. We will target identified molecular adaptations in distinct cell
subtypes to determine their role in circuit and emotional behavioral disruptions occurring with perinatal fentanyl
exposure. Our studies will, for the first time, uncover cellular, circuit, and molecular adaptations occurring after
perinatal exposure to fentanyl and determine the circuitry mediating the long lasting neurobiological anomalies
that occur with perinatal opioid exposure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Single-cell multi-omics of cerebellar dysregulation in schizophrenia and bipolar disorder
-
批准号:10348993
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2022
-
负责人:Seth Abrams Ament
-
依托单位:
Single-cell multi-omics of cerebellar dysregulation in schizophrenia and bipolar disorder
-
批准号:10555339
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2022
-
负责人:Seth Abrams Ament
-
依托单位:
Multi-scale consequences of variants in the schizophrenia risk gene SETD1A in a population isolate.
-
批准号:10678897
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Seth Abrams Ament
-
依托单位:
Genomic profiling mediating the protective effect of social reward on opioid craving
-
批准号:10671062
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2022
-
负责人:Seth Abrams Ament
-
依托单位:
Genomic profiling mediating the protective effect of social reward on opioid craving
-
批准号:10505240
-
项目类别:
-
资助金额:$68.43万
-
财政年份:2022
-
负责人:Seth Abrams Ament
-
依托单位:
Lasting Neurological Effects of Perinatal Opioids
-
批准号:10708784
-
项目类别:
-
资助金额:$71.86万
-
财政年份:2022
-
负责人:Seth Abrams Ament
-
依托单位:
Multi-scale consequences of variants in the schizophrenia risk gene SETD1A in a population isolate.
-
批准号:10415243
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Seth Abrams Ament
-
依托单位:
Heroin-Induced genomic regulation of Ventral Pallidum neuron subtypes
-
批准号:10210378
-
项目类别:
-
资助金额:$66.76万
-
财政年份:2020
-
负责人:Seth Abrams Ament
-
依托单位:
Heroin-Induced genomic regulation of Ventral Pallidum neuron subtypes
-
批准号:10057036
-
项目类别:
-
资助金额:$68.23万
-
财政年份:2020
-
负责人:Seth Abrams Ament
-
依托单位:
Heroin-Induced genomic regulation of Ventral Pallidum neuron subtypes
-
批准号:10404982
-
项目类别:
-
资助金额:$59.33万
-
财政年份:2020
-
负责人:Seth Abrams Ament
-
依托单位:
Heroin-Induced genomic regulation of Ventral Pallidum neuron subtypes
-
批准号:10646307
-
项目类别:
-
资助金额:$59.06万
-
财政年份:2020
-
负责人:Seth Abrams Ament
-
依托单位:
海外基金